Invest1 distinct publisher3 min readPublished
The Foundation screened for holders above 0.25% of supply who had sold after 10 October 2025, bought their unvested tokens over the counter, and set 5 October 2026 as the date the unlock calendar stops. Non-sellers were offered their cost back and refused.
The Investor · Invest desk

Compiled by The InvestorSomething wrong?How this is made
The qualifying test for the buyout is where the information sits: you had to have been allocated more than 0.25% of total supply, and you had to have sold some ENA after the market peak on 10 October 2025 [2]. So the Foundation did not retire locked supply as a category, it retired the wallets that had already demonstrated what they would do with it. Holders in that bracket who had sat through the drawdown got a different offer, their original cost with no discount, and none of them took it [3], while one wallet that had been selling also passed, citing conviction in the project [4].
Declining a return of capital at par is a valuation statement from the people with the best view of the book, and it is the part of this package that argues against reading the whole thing as a distress operation. It is also worth adding up what remains: about 12% of supply still locked with team, ecosystem and Foundation after the early close [6], plus the roughly 20% that StablecoinX holds under a separate lockup disclosed in its SEC filings [7], which is about 32% of supply restricted in one form or another [14]. The quantity is largely unchanged; what ends is the published monthly schedule that told the market when the next tranche was arriving [5], and that end date falls 360 days after the peak that defined the seller screen [16].
The revenue side is a percentage waiting for a base. Once circulating USDe supply clears the first milestone, 95% of net revenue paid to the Foundation from USDe savings, white-label stablecoins and the shortly-to-launch Ethena [X] goes to programmatic buying, with 5% held for growth [11], and the share steps up as further supply milestones are reached [10]. The announcement gives the share and not the amount [17], and the schedule is described as supporting a return toward prior scale [13], which is a careful way of recording that USDe supply is below where it was.
This reading may be wrong in some respect, but Ethena has effectively conceded that the unlock calendar, not usage, was the variable setting its price. If the marginal seller really was the unlock calendar, then closing it and adding a revenue-funded bid does the work, and the Master Framework Agreement, which assigns protocol IP and residual profit to the Foundation and leaves Labs equity holders with no residual cash flow [8], makes the token the only instrument with a claim on the business, though the Foundation is at pains to note that Labs shareholders never took protocol revenue through dividends in the first place, with the full agreement due in October 2026 [9]. If the marginal seller was instead shrinking demand for USDe, then 95% of a smaller number is a smaller bid and the calendar was a symptom. The third path requires no vote at all: the 12% sitting with team, ecosystem and Foundation becomes the supply question the moment investors stop being one. The test is at least legible, since buybacks are tracked on a public dashboard and Ethena has filed under the Blockworks Token Transparency Framework [12], so the record is public: the first milestone has been reached, the buyback is printing, the price is still lagging, and the unlock diagnosis was wrong.
Ranked by verification strength, evidence, and original report placement.
The Foundation completed over-the-counter purchases of remaining locked ENA from a group of large seed investors, targeting holders originally allocated more than 0.25% of total supply who had sold any ENA after the market peak on 10 October 2025.
StablecoinX, a large related holder, continues to hold roughly 20% of supply under a separate lockup disclosed in its SEC filings.
The Ethena Foundation published a package of four changes aimed at monthly selling pressure from early backers and at who captures the economic value the protocol produces.
Investors who had not sold during that window were offered a repurchase at their original cost with no discount, and none accepted.
One wallet among those who had sold also declined the buyout, citing conviction in the project.
The Foundation and lead investors agreed to bring the remaining original investor vesting to an early close, so that from 5 October 2026 no investor tokens stay locked, ending the monthly unlock calendar that had weighed on sentiment.
Distinct publishers with included, body-backed reporting in this cluster.
Follow any of these and your For You feed starts watching them — no settings page required.
invest
Ethena pays to retire the seed tokens its early backers were already selling1 distinct publisher
invest
FalconX and Ethena Wrap $1B of Credit in an SPV, and That Is the Point1 distinct publisher
invest
Ceffu moved $120M out of Ethena's custody wallets, and nobody has said why1 distinct publisher
invest
Ethena's synthetic dollar climbs to second place on Base in ninety days1 distinct publisher
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One outlet, relaying the issuer
Every figure that gives this story its shape — the 0.25% allocation screen, the 12% still locked, StablecoinX's 20%, the 95/5 split — reaches us through a single Crowdfund Insider write-up of the Foundation's own package. The lone external anchor, StablecoinX's SEC filings, is pointed at rather than quoted. Nothing here shows the completed over-the-counter purchases on-chain, names a price paid, or reproduces the framework agreement, which does not yet exist in final form.
Two pieces done, two pieces pending
Split the package and the picture clarifies. The buyouts are described as finished and the vesting change as agreed, which is real movement on the overhang. The two parts that would actually redirect money — the fee switch and the transfer of protocol economics away from Labs equity — are a live vote and a document due in October 2026 respectively. No buyback has been executed, no milestone has been reported as hit, and no USDe supply or revenue figure appears to gauge how close one is.
The headline number is the least settled part
"95% of net revenue to buybacks" is the line that travels, and it is conditional on a milestone whose threshold is never stated, funded partly by a product that has not launched, and dependent on a vote that has not happened. The same package quietly leaves about a third of supply restricted, most of it with StablecoinX, while framing itself as closing the unlock question. The overstatement is in the framing, not the facts: the buyout of the investors who sold after the October peak is specific, dated and, as told, done.
The issuer set the terms and the yardstick
The Foundation is announcing its own remedy for its own token's overhang, and it controls each measuring instrument: it defined the screen that decided which investors were bought out, it will run the dashboard that records the buybacks, and it chose the disclosure standard it filed under. The Labs-versus-token-holder restructuring is a deal whose counterparties are also its only narrators, and the assertion that Labs shareholders never took protocol revenue is precisely the sort of negative an interested party has reason to volunteer.
Clear on what was said, untested on what was done
We can be fairly sure this is a faithful rendering of the Foundation's announcement — the dates, screens and percentages are internally consistent and specific enough to check later. What we cannot do yet is confirm any of it independently, and the two forward-dated commitments could look materially different by October 2026. Treat the mechanics as reliably reported and the outcomes as unverified.